The dominant effects of rp/+ mutations also extend to humans, where several pathologies, collectively termed ribosomopathies, are caused by heterozygosity for Rp mutations, and lead to tissue-specific effects such as blood disorders, congenital growth defects, and predisposition to cancer [16–18]. Here, BLOC1S3 is linked to cancer.